Related Experiment Video
Updated: May 17, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Thyroid volume and severity of Graves' orbitopathy
Maria Antonietta Profilo1, Eleonora Sisti, Claudio Marcocci
1Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Thyroid : Official Journal of the American Thyroid Association
|October 24, 2012
Summary
Thyroid volume correlates with Graves
Area of Science:
- Endocrinology
- Ophthalmology
- Immunology
Background:
- Graves' orbitopathy (GO) pathogenesis is linked to shared autoantigens in thyroid and orbital tissues.
- Severity of GO may correlate with thyroid gland size, similar to hyperthyroidism severity in Graves' disease.
- Investigated the relationship between thyroid volume and GO severity at initial presentation.
Purpose of the Study:
- To determine if thyroid volume correlates with the severity of Graves' orbitopathy (GO).
- To explore potential links between thyroid size and clinical manifestations of GO.
Main Methods:
- Retrospective analysis of 86 untreated GO patients within 24 months of onset.
- Evaluated ophthalmological parameters: exophthalmometry, eyelid width, clinical activity score (CAS), diplopia, visual acuity.
- Assessed GO severity using NOSPECS and modified NOSPECS scores, correlating with thyroid volume and other clinical/biochemical markers.
Main Results:
- Thyroid volume significantly correlated with exophthalmometry (p=0.02) and CAS (p=0.02) via simple regression.
- Both standard and modified NOSPECS scores showed correlation with thyroid volume (p=0.02 and p=0.007, respectively).
- Thyroid volume remained a significant predictor for GO severity even in multiple regression analysis (p=0.05).
Conclusions:
- Thyroid volume is a significant correlate of Graves' orbitopathy severity, particularly exophthalmometry and CAS.
- Findings support a potential pathogenetic role for shared thyroid-orbital autoantigens.
- Alternative explanations include a generally more reactive immune system in patients with larger goiters.
Related Concept Videos
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
